Pricing
Login
Home
Charts
Search
Watchlist
Products

Torrent Pharmaceuticals Ltd

TORNTPHARM
₹4,689.50+1.70%20 Nov 2026
Reports
Pharma Formulations

Torrent Pharmaceuticals Ltd

TORNTPHARM
₹4,689.50
+1.70%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,78,374Cr
Close
Close Price
₹4,689.50
Industry
Industry
Pharma Formulations
PE
Price To Earnings
79.21
PS
Price To Sales
10.25
Revenue
Revenue
₹17,400Cr
Rev Gr TTM
Revenue Growth TTM
42.06%
PAT Gr TTM
PAT Growth TTM
-1.92%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
2,7322,7452,8592,8892,8092,9593,1783,3023,3034,1974,9214,979
Growth YoY
Revenue Growth YoY%
9.710.210.38.62.87.811.214.317.641.854.950.8
Expenses
ExpensesCr
1,8631,8621,9551,9501,8951,9952,1462,2192,2152,8413,2573,313
Operating Profit
Operating ProfitCr
8698839049399149641,0321,0831,0881,3561,6641,666
OPM
OPM%
31.832.231.632.532.532.632.532.832.932.333.833.5
Other Income
Other IncomeCr
553124-1633-42-37-40-23-83-33-20
Interest Expense
Interest ExpenseCr
808075645756564845236305300
Depreciation
DepreciationCr
213203197198199201201204206508593609
PBT
PBTCr
631631656661691665738791814529733737
Tax
TaxCr
188182199208188167190200179165167203
PAT
PATCr
443449457453503498548591635364566534
Growth YoY
PAT Growth YoY%
51.756.520.917.413.510.919.930.526.2-26.93.3-9.6
NPM
NPM%
16.216.416.015.717.916.817.217.919.28.711.510.7
EPS
EPS₹
13.113.313.513.414.914.716.217.418.811.514.914.1
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
2,7322,7452,8592,8892,8092,9593,1783,3023,3034,1974,9214,979
Growth YoY
Revenue Growth YoY%
9.710.210.38.62.87.811.214.317.641.854.950.8
Expenses
ExpensesCr
1,8631,8621,9551,9501,8951,9952,1462,2192,2152,8413,2573,313
Operating Profit
Operating ProfitCr
8698839049399149641,0321,0831,0881,3561,6641,666
OPM
OPM%
31.832.231.632.532.532.632.532.832.932.333.833.5
Other Income
Other IncomeCr
553124-1633-42-37-40-23-83-33-20
Interest Expense
Interest ExpenseCr
808075645756564845236305300
Depreciation
DepreciationCr
213203197198199201201204206508593609
PBT
PBTCr
631631656661691665738791814529733737
Tax
TaxCr
188182199208188167190200179165167203
PAT
PATCr
443449457453503498548591635364566534
Growth YoY
PAT Growth YoY%
51.756.520.917.413.510.919.930.526.2-26.93.3-9.6
NPM
NPM%
16.216.416.015.717.916.817.217.919.28.711.510.7
EPS
EPS₹
13.113.313.513.414.914.716.217.418.811.514.914.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6,6875,8575,9507,6737,9398,0058,5089,62010,72811,51613,98017,400
Growth
Revenue Growth%
43.7-12.41.629.03.50.86.313.111.57.321.442.1
Expenses
ExpensesCr
3,9544,4804,6015,6905,7695,5246,0776,7787,3607,7959,42111,626
Operating Profit
Operating ProfitCr
2,7331,3771,3491,9832,1702,4802,4312,8423,3683,7214,5585,774
OPM
OPM%
40.923.522.725.927.331.028.629.531.432.332.633.2
Other Income
Other IncomeCr
32223299-30012157-28845146-1-182-159
Interest Expense
Interest ExpenseCr
184206308504451353255333354252385886
Depreciation
DepreciationCr
2383074096186546586627078087951,1191,916
PBT
PBTCr
2,3431,0889315621,1871,5261,2261,8472,3522,6732,8722,813
Tax
TaxCr
610155253125162274449602696762734714
PAT
PATCr
1,7339346784361,0251,2527771,2451,6561,9112,1382,099
Growth
PAT Growth%
130.8-46.1-27.4-35.7134.922.2-37.960.233.015.411.9-1.9
NPM
NPM%
25.915.911.45.712.915.69.112.915.416.615.312.1
EPS
EPS₹
51.227.620.012.930.337.023.036.848.956.563.959.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6,6875,8575,9507,6737,9398,0058,5089,62010,72811,51613,98017,400
Growth
Revenue Growth%
43.7-12.41.629.03.50.86.313.111.57.321.442.1
Expenses
ExpensesCr
3,9544,4804,6015,6905,7695,5246,0776,7787,3607,7959,42111,626
Operating Profit
Operating ProfitCr
2,7331,3771,3491,9832,1702,4802,4312,8423,3683,7214,5585,774
OPM
OPM%
40.923.522.725.927.331.028.629.531.432.332.633.2
Other Income
Other IncomeCr
32223299-30012157-28845146-1-182-159
Interest Expense
Interest ExpenseCr
184206308504451353255333354252385886
Depreciation
DepreciationCr
2383074096186546586627078087951,1191,916
PBT
PBTCr
2,3431,0889315621,1871,5261,2261,8472,3522,6732,8722,813
Tax
TaxCr
610155253125162274449602696762734714
PAT
PATCr
1,7339346784361,0251,2527771,2451,6561,9112,1382,099
Growth
PAT Growth%
130.8-46.1-27.4-35.7134.922.2-37.960.233.015.411.9-1.9
NPM
NPM%
25.915.911.45.712.915.69.112.915.416.615.312.1
EPS
EPS₹
51.227.620.012.930.337.023.036.848.956.563.959.2
Sales CAGR
1 Year21%
3 Years13%
5 Years12%
TTM42%
EBITDA CAGR
1 Year23%
3 Years17%
5 Years13%
TTM45%
PAT CAGR
1 Year12%
3 Years20%
5 Years11%
TTM-2%
Avg. ROCE
1 Year14%
3 Years22%
5 Years20%
TTM11%
CFO / EBITDA
1 Year66%
3 Years76%
5 Years77%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
85858585858585169169169169190
Reserves
ReservesCr
3,4094,2664,5384,6404,7395,7535,8686,0296,6877,4218,21918,183
Current Liabilities
Current LiabilitiesCr
3,2852,7385,2025,1655,4544,8924,4155,4475,4254,7178,3437,984
Non Current Liabilities
Non Current LiabilitiesCr
2,2782,6134,4184,2313,7323,3462,7323,3662,7792,68218,38418,258
Total Liabilities
Total LiabilitiesCr
9,0589,70214,24314,12114,01014,07513,10015,01215,06114,99044,31244,615
Current Assets
Current AssetsCr
4,6884,8795,2625,0384,9795,5225,1655,3145,6115,6239,39210,517
Non Current Assets
Non Current AssetsCr
4,3704,8238,9819,0839,0318,5537,9359,6989,4499,36734,92034,097
Total Assets
Total AssetsCr
9,0589,70214,24314,12114,01014,07513,10015,01215,06114,99044,31244,615
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
85858585858585169169169169190
Reserves
ReservesCr
3,4094,2664,5384,6404,7395,7535,8686,0296,6877,4218,21918,183
Current Liabilities
Current LiabilitiesCr
3,2852,7385,2025,1655,4544,8924,4155,4475,4254,7178,3437,984
Non Current Liabilities
Non Current LiabilitiesCr
2,2782,6134,4184,2313,7323,3462,7323,3662,7792,68218,38418,258
Total Liabilities
Total LiabilitiesCr
9,0589,70214,24314,12114,01014,07513,10015,01215,06114,99044,31244,615
Current Assets
Current AssetsCr
4,6884,8795,2625,0384,9795,5225,1655,3145,6115,6239,39210,517
Non Current Assets
Non Current AssetsCr
4,3704,8238,9819,0839,0318,5537,9359,6989,4499,36734,92034,097
Total Assets
Total AssetsCr
9,0589,70214,24314,12114,01014,07513,10015,01215,06114,99044,31244,615

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
2,7421,0098941,7981,3932,0051,8032,3683,2662,5853,023
Investing Cash Flow
Investing Cash FlowCr
-838-787-4,707-241199-449-197-2,415-168-540-12,712
Financing Cash Flow
Financing Cash FlowCr
-1,435-1933,417-1,314-1,549-1,651-1,78177-2,780-2,29810,151
Net Cash Flow
Net Cash FlowCr
46929-39524242-95-17530319-253461
Free Cash Flow
Free Cash FlowCr
2,1505231051,1389901,6711,6071,9532,9671,9912,386
CFO To PAT
CFO To PAT%
158.2108.1131.8412.1135.9160.2232.0190.2197.2135.3141.4
CFO To EBITDA
CFO To EBITDA%
100.373.366.390.764.280.974.283.397.069.566.3
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
2,7421,0098941,7981,3932,0051,8032,3683,2662,5853,023
Investing Cash Flow
Investing Cash FlowCr
-838-787-4,707-241199-449-197-2,415-168-540-12,712
Financing Cash Flow
Financing Cash FlowCr
-1,435-1933,417-1,314-1,549-1,651-1,78177-2,780-2,29810,151
Net Cash Flow
Net Cash FlowCr
46929-39524242-95-17530319-253461
Free Cash Flow
Free Cash FlowCr
2,1505231051,1389901,6711,6071,9532,9671,9912,386
CFO To PAT
CFO To PAT%
158.2108.1131.8412.1135.9160.2232.0190.2197.2135.3141.4
CFO To EBITDA
CFO To EBITDA%
100.373.366.390.764.280.974.283.397.069.566.3

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
22,67026,21621,11733,03533,36243,00347,32052,03188,0351,09,4741,42,8461,78,374
Price To Earnings
Price To Earnings
13.128.131.175.732.634.460.941.853.157.366.079.2
Price To Sales
Price To Sales
3.44.53.54.34.25.45.65.48.26.67.410.3
Price To Book
Price To Book
6.56.04.67.06.97.48.08.412.814.417.09.7
EV To EBITDA
EV To EBITDA
8.720.019.318.717.119.121.020.027.130.134.433.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
73.064.567.367.369.469.667.468.171.872.872.772.7
OPM
OPM%
40.923.522.725.927.331.028.629.531.432.332.633.2
NPM
NPM%
25.915.911.45.712.915.69.112.915.416.615.312.1
ROCE
ROCE%
47.319.612.011.117.817.514.818.924.927.113.911.5
ROE
ROE%
49.621.514.79.221.321.413.120.124.225.225.511.4
ROA
ROA%
19.19.64.83.17.38.95.98.311.012.84.84.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
22,67026,21621,11733,03533,36243,00347,32052,03188,0351,09,4741,42,8461,78,374
Price To Earnings
Price To Earnings
13.128.131.175.732.634.460.941.853.157.366.079.2
Price To Sales
Price To Sales
3.44.53.54.34.25.45.65.48.26.67.410.3
Price To Book
Price To Book
6.56.04.67.06.97.48.08.412.814.417.09.7
EV To EBITDA
EV To EBITDA
8.720.019.318.717.119.121.020.027.130.134.433.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
73.064.567.367.369.469.667.468.171.872.872.772.7
OPM
OPM%
40.923.522.725.927.331.028.629.531.432.332.633.2
NPM
NPM%
25.915.911.45.712.915.69.112.915.416.615.312.1
ROCE
ROCE%
47.319.612.011.117.817.514.818.924.927.113.911.5
ROE
ROE%
49.621.514.79.221.321.413.120.124.225.225.511.4
ROA
ROA%
19.19.64.83.17.38.95.98.311.012.84.84.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr4,52,2511,78,3741,19,7001,16,1191,14,3161,10,0771,03,510
Close PriceClose₹1,884.904,689.501,200.001,390.201,415.002,665.001,799.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE41.2579.2128.6741.3639.4549.0526.09
Price To SalesPS7.3410.253.943.514.067.162.80
RevenueRevenueCr61,63117,40030,37833,09728,13915,37936,913
Revenue Growth TTMRev Gr TTM%12.1%42.1%24.0%-3.5%-0.7%13.5%13.5%
PAT Growth TTMPAT Gr TTM%4.9%-1.9%-14.6%-51.9%-47.4%27.6%16.5%
Market CapitalizationMkt CapCr4,52,2511,78,3741,19,7001,16,1191,14,3161,10,0771,03,510
Close PriceClose₹1,884.904,689.501,200.001,390.201,415.002,665.001,799.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE41.2579.2128.6741.3639.4549.0526.09
Price To SalesPS7.3410.253.943.514.067.162.80
RevenueRevenueCr61,63117,40030,37833,09728,13915,37936,913
Revenue Growth TTMRev Gr TTM%12.1%42.1%24.0%-3.5%-0.7%13.5%13.5%
PAT Growth TTMPAT Gr TTM%4.9%-1.9%-14.6%-51.9%-47.4%27.6%16.5%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
ResultPPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
ResultPPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
ResultPPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
ResultPPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Load More
Interviews